Clinical Trials Logo

Clinical Trial Summary

The project is designed as a cross-sectional study and aims to examine middle- to long-term consequences of coronavirus disease 2019 (COVID-19) for selected bio-behavioural parameters while taking the disease course severity into account.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05118711
Study type Observational
Source University of Basel
Contact Arno Schmidt-Trucksäss, Prof.
Phone +41 61 207 47 40
Email [email protected]
Status Not yet recruiting
Start date January 2022
Completion date May 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04866082 - Corticosteroids in Severe COVID-19 (ASAP-ESICM/ESAIC Study)
Active, not recruiting NCT04918901 - Comparative Analysis of Clinical Parameters and Radiographic Changes of Severe COVID-19
Not yet recruiting NCT04613986 - Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19 N/A
Recruiting NCT04733833 - A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19 Phase 2
Recruiting NCT04712344 - Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO) Phase 2
Recruiting NCT04713176 - Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients Phase 3
Recruiting NCT04648410 - Corticosteroids in Severe COVID-19(ASAP-C Study)